Detalhe da pesquisa
1.
Defibrotide improves COVID-19-related acute respiratory distress syndrome in myeloma patients after chimeric antigen receptor T-cell treatment without compromising virus-specific and anti-myeloma T-cell responses.
Haematologica
; 2024 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38385273
2.
Idecabtagene vicleucel chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma with renal impairment.
Haematologica
; 109(3): 777-786, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37731379
3.
A novel multicolor fluorescent spot assay for the functional assessment of chimeric antigen receptor (CAR) T-cell products.
Cytotherapy
; 26(4): 318-324, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38340107
4.
Factors associated with refractoriness or early progression after idecabtagene vicleucel in patients with relapsed/refractory multiple myeloma: U.S. Myeloma Immunotherapy Consortium real world experience.
Haematologica
; 2023 10 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37855036
5.
Comparison of two different bone anchored hearing instruments.
Eur Arch Otorhinolaryngol
; 280(5): 2141-2147, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36214870
6.
Revisiting the Case of Sarah Newbury's Death from Mollities Ossium.
Cancer Invest
; 40(6): 544-553, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35275786
7.
The impact of bridging therapy prior to CD19-directed chimeric antigen receptor T-cell therapy in patients with large B-cell lymphoma.
Br J Haematol
; 195(3): 405-412, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34500492
8.
Pembrolizumab, pomalidomide, and low-dose dexamethasone for relapsed/refractory multiple myeloma.
Blood
; 130(10): 1189-1197, 2017 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28461396
9.
Vaccine-induced T-cell responses against SARS-CoV-2 and its Omicron variant in patients with B cell-depleted lymphoma after CART therapy.
Blood
; 140(2): 152-156, 2022 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35537186
10.
Clinical and pharmacodynamic analysis of pomalidomide dosing strategies in myeloma: impact of immune activation and cereblon targets.
Blood
; 125(26): 4042-51, 2015 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-25869284
11.
Chimeric antigen receptor T-cell therapy after allogeneic stem cell transplant for relapsed/refractory large B-cell lymphoma.
Br J Haematol
; 192(1): 212-216, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33169845
12.
Therapeutic strategies for durable response in plasma cell granulomas in the central nervous system.
Ann Hematol
; 98(4): 1027-1029, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30178192
13.
Rapid relapse of large B-cell lymphoma after CD19 directed CAR-T-cell therapy due to CD-19 antigen loss.
Am J Hematol
; 94(10): E273-E275, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31342556
14.
Refractory postallogeneic stem cell transplant pure red cell aplasia in remission after treatment with daratumumab.
Am J Hematol
; 94(8): E216-E219, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31120638
15.
Racial and ethnic differences in clinical outcomes among patients with multiple myeloma treated with CAR T-cell therapy.
Blood Adv
; 8(1): 251-259, 2024 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37855718
16.
Ocular adverse events associated with chimeric antigen receptor T-cell therapy: a case series and review.
Br J Ophthalmol
; 107(7): 901-905, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35144919
17.
Outcomes of Busulfan, Fludarabine, and 400 cGy Total Body Irradiation Compared With Busulfan and Fludarabine Reduced-Intensity Conditioning Regimens for Allogeneic Stem Cell Transplantation in Adult Patients With Hematologic Diseases: A Single-Center Experience.
Transplant Proc
; 55(1): 214-224, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36635141
18.
Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: Real-World Experience From the Myeloma CAR T Consortium.
J Clin Oncol
; 41(11): 2087-2097, 2023 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36623248
19.
Imaging Biomarkers to Predict Outcomes in Patients With Large B-Cell Lymphoma With a Day 28 Partial Response by 18F-FDG PET/CT Imaging Following CAR-T Therapy.
Clin Lymphoma Myeloma Leuk
; 23(10): 757-763, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37453865
20.
Prolonged Lenalidomide Induction Does Not Significantly Impair Stem Cell Collection in Multiple Myeloma Patients Mobilized With Cyclophosphamide or Plerixafor: A Report From The Covid Era.
Clin Lymphoma Myeloma Leuk
; 22(8): e716-e729, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35504807